← back to search

Alan Herschtal

Monash University · AU
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Radiation →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Advanced Radiotherapy Techniques, Lung Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, and Radiomics and Machine Learning in Medical Imaging.
h-index
32
citations
5,801
works
106
NIH funding
primary concept
Medicine
email

Recent publications

Comparison of Changes in Pulmonary Function After Stereotactic Body Radiation Therapy Versus Conventional 3-Dimensional Conformal Radiation Therapy for Stage I and IIA Non-Small Cell Lung Cancer: An Analysis of the TROG 09.02 (CHISEL) Phase 3 Trial
International Journal of Radiation Oncology*Biology*Physics 2023cited by 6position: middledoi
Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study
International Journal of Radiation Oncology*Biology*Physics 2021cited by 146position: middledoi
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
The Lancet 2020cited by 1,925position: middledoi
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
The Lancet Oncology 2020cited by 360position: middledoi
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Nature reviews. Cancer 2019cited by 51position: middledoi
A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial
International Journal of Radiation Oncology*Biology*Physics 2019cited by 41position: middledoi
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
Blood 2014cited by 102position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Richard Fisher · Cambridge University Press3 papers (2019–2021)Gillian Duchesne · Peter MacCallum Cancer Centre2 papers (2019–2020)Colin Tang · Sir Charles Gairdner Hospital2 papers (2019–2020)Jarad Martin · Calvary Mater Newcastle Hospital2 papers (2019–2020)Tee Lim · Murdoch University2 papers (2019–2020)Maria Pearse · Auckland City Hospital2 papers (2019–2020)Mark Frydenberg · Monash Medical Centre2 papers (2019–2020)Andrew Kneebone · University of Sydney2 papers (2019–2020)Jeremy Millar · Monash Health2 papers (2019–2020)Nigel Spry · Edith Cowan University2 papers (2019–2020)Henry H. Woo · Blacktown & Mount Druitt Hospital2 papers (2019–2020)Scott Williams · The University of Sydney2 papers (2019–2020)Carol Fraser‐Browne · Auckland City Hospital2 papers (2019–2020)David Joseph · TH Bingen University of Applied Sciences2 papers (2019–2020)Annette Haworth · Sydney Local Health District2 papers (2019–2020)Mark Sidhom · Liverpool Hospital2 papers (2019–2020)Susan Branford · Royal Adelaide Hospital1 papers (2014–2014)Ellen L. Goode · Mayo Clinic1 papers (2019–2019)Margaret McGrath · University of Washington1 papers (2021–2021)Andrew Macann · University of Auckland1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Radiation →